CTRICHMOND, Va., Jul 8, 2002 (BW HealthWire) -- Insmed Incorporated (Nasdaq:INSM), a biopharmaceutical company focused on the development of drug candidates for the treatment of type 2 diabetes and other metabolic and endocrine disorders, will host a conference call on Tuesday, July 9, 2002, at 9:00 a.m. Eastern Time (8 a.m. Central Time). President, Chief Executive Officer and Chairman, Geoffrey Allan, Ph.D., will conduct the call. To participate in the conference call dial 888/606-5911, password: INSMED. A live audio feed of the web cast can be accessed through the Investor Relations link on the Company's website: www.insmed.com. A telephonic replay of the call will be available for one week and can be accessed at 800/685-2427. A web replay of the call will be available through the Investor Relations website beginning at 11:00 a.m.
About Insmed Incorporated
Insmed Incorporated is a biopharmaceutical company focused on the development of drug candidates for the treatment of metabolic and endocrine disorders.
Further information is available at www.insmed.com.
CONTACT: Insmed Incorporated, Richmond Baxter Phillips, III, 804/565-3041 bphillips@insmed.com
News Releases
Insmed Incorporated Announces Investor Update Conference Call; Tuesday, July 9, 2002, at 9:00 a.m. ET - 8:00 a.m. CT
Insmed Incorporated Announces Investor Update Conference Call; Tuesday, July 9, 2002, at 9:00 a.m. ET - 8:00 a.m. CT
